Camden National director awarded 308 shares

Q: What did Camden National (CAC) disclose in this Form 4 filing?

Camden National disclosed that director Carl John Soderberg received a grant of 308 common shares on June 18, 2026. The award was issued under the company’s 2022 Equity and Incentive Plan as compensation in lieu of cash director fees.

Q: How many Camden National (CAC) shares were granted to Carl John Soderberg?

Carl John Soderberg was granted 308 shares of Camden National common stock. These shares were awarded as a non-cash form of director compensation, rather than an open-market purchase, under the company’s 2022 Equity and Incentive Plan and Amendment.

Q: At what price were the new Camden National (CAC) shares recorded in the Form 4?

The 308 awarded shares were recorded at $51.49 per share. This price is used for reporting purposes in the Form 4 and reflects the value assigned to the equity award granted in lieu of traditional cash director fees on the grant date.

Q: Is the Camden National (CAC) Form 4 transaction an open-market purchase or compensation grant?

The transaction is a compensation-related grant, not an open-market purchase. The 308 shares were acquired under Camden National’s 2022 Equity and Incentive Plan in lieu of director fees, reflecting stock-based compensation rather than a discretionary market trade.

Camden National Corp director Carl John Soderberg received an equity award of 308 shares of common stock on June 18, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Camden National Corp director Carl John Soderberg received an equity award of 308 shares of common stock on June 18, 2026. The shares were acquired under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees, at a reference price of $51.49 per share. Following this compensation-related grant, Soderberg directly holds 104,349.218 Camden National common shares.

Insider Trade Summary

Grant/Award: 308 shares

Grant/Award 1 txn

Insider Soderberg Carl John

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common	308	$51.49	$16K

Holdings After Transaction: Common — 104,349.218 shares (Direct)

Footnotes (1)

F1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Key Figures

Shares granted: 308 shares Grant reference price: $51.49 per share Shares held after transaction: 104,349.218 shares +2 more

5 metrics

Shares granted 308 shares Equity award in lieu of director fees on June 18, 2026

Grant reference price $51.49 per share Reported price for 308-share award

Shares held after transaction 104,349.218 shares Direct holdings after June 18, 2026 grant

Transaction type Grant, award, or other acquisition Form 4 code A, non-derivative common stock

Acquire transactions in filing 1 transaction Form 4 transaction summary acquireCount

Key Terms

2022 Equity and Incentive Plan, grant/award acquisition, Form 4, director fees

4 terms

2022 Equity and Incentive Plan financial

"Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees."

grant/award acquisition financial

"transaction_action: "grant/award acquisition" with transaction_code_description "Grant, award, or other acquisition"."

Form 4 regulatory

"INSIDER FILING DATA (Form 4) reporting non-derivative common stock transaction for a director."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

director fees financial

"Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Camden National (CAC) disclose in this Form 4 filing?

Camden National disclosed that director Carl John Soderberg received a grant of 308 common shares on June 18, 2026. The award was issued under the company’s 2022 Equity and Incentive Plan as compensation in lieu of cash director fees.

How many Camden National (CAC) shares were granted to Carl John Soderberg?

Carl John Soderberg was granted 308 shares of Camden National common stock. These shares were awarded as a non-cash form of director compensation, rather than an open-market purchase, under the company’s 2022 Equity and Incentive Plan and Amendment.

At what price were the new Camden National (CAC) shares recorded in the Form 4?

The 308 awarded shares were recorded at $51.49 per share. This price is used for reporting purposes in the Form 4 and reflects the value assigned to the equity award granted in lieu of traditional cash director fees on the grant date.

How many Camden National (CAC) shares does Carl John Soderberg hold after this grant?

After the 308-share award, Carl John Soderberg directly holds 104,349.218 shares of Camden National common stock. This figure represents his direct ownership position immediately following the June 18, 2026 equity grant reported in the Form 4 filing.

Is the Camden National (CAC) Form 4 transaction an open-market purchase or compensation grant?

The transaction is a compensation-related grant, not an open-market purchase. The 308 shares were acquired under Camden National’s 2022 Equity and Incentive Plan in lieu of director fees, reflecting stock-based compensation rather than a discretionary market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/23/2026 - 01:39 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Soderberg Carl John

(Last)

(First)

(Middle)

2 ELM STREET

PO BOX 310

(Street)

CAMDEN

MAINE

04843

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common	06/18/2026		A		308⁽¹⁾	A	$51.49	104,349.218	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Remarks:

	Christopher G. Hutchinson, POA	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR